obsolete_alpha-1-antitrypsin deficiency: ['A lung disease that is characterized as a genetic disorder caused by defective production of alpha 1-antitrypsin (A1AT), leading to decreased A1AT activity in the blood and lungs, and deposition of excessive abnormal A1AT protein in liver cells. Alpha-1 antitrypsin works to protect the lungs from a naturally occuring destructive enzyme that is produced by the lungs in response to infections and toxins (such as cigarette smoke). Without enough A1AT, these enzymes slowly destroy the lung tissue causing emphysema. The symptoms include shortness of breath, wheezing, rhonchi, and rales.']
Disorders of plasma-protein metabolism, not elsewhere classified
DOID EFO Endpoint Browser PheWeb
E4_PLASMAPROT
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
246 |
4. Check minimum number of eventsNone |
246 |
5. Include endpointsNone |
246 |
6. Filter based on genotype QC (FinnGen only) |
246 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E88
- Name in latin
- Perturbationes metabolismi proteinorum plasmaticorum non alibi classificatae
Similar endpoints
↥List of similar endpoints to
Disorders of plasma-protein metabolism, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other metabolic disorders
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1574 | 706 | 856 |
| Only index persons | 1269 | 601 | 668 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 46.52 | 47.95 | 45.18 |
| Only index persons | 46.35 | 47.73 | 45.10 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 246 | 124 | 122 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.05 |
| Median age at first event (years) | 53.84 | 53.44 | 54.25 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 222
- Matched controls
- 2219
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E88.0
ICD-10 Finland
Disorders of plasma-protein metabolism, not elsewhere classified
+∞
318.2
221
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
16.1
46.4
80
75
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
7.6
37.7
108
245
R03BB04
ATC
tiotropium bromide; inhalant
10.5
34.5
73
99
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
18.7
31.4
49
33
J45.9
ICD-10 Finland
Asthma, unspecified
6.1
27.4
88
215
R03AC02
ATC
salbutamol; inhalant
5.1
26.7
168
843
R03AK06
ATC
salmeterol and fluticasone; inhalant
7.0
26.7
74
148
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
24.2
137
591
J45.1
ICD-10 Finland
Nonallergic asthma
8.2
23.5
56
88
GD1AD
NOMESCO Finland
Thorax CT examination
12.9
21.7
39
36
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
10.8
20.4
40
44
Z94.2
ICD-10 Finland
Lung transplant status
+∞
20.1
19
*
R03DA04
ATC
theophylline; systemic, rectal
13.2
19.8
35
31
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
206.7
18.8
19
*
XG410
NOMESCO Finland
Flow-volume spirometry
11.7
18.7
35
35
H02AB06
ATC
prednisolone; systemic
3.6
18.5
138
692
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
20.3
18.3
27
15
127
Kela drug reimbursment
Transplant complication
23.3
17.7
25
12
J43.9
ICD-10 Finland
Emphysema, unspecified
21.5
17.3
25
13
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.8
17.2
94
360
R03AK07
ATC
formoterol and budesonide; inhalant
4.2
16.9
74
234
R03AC12
ATC
salmeterol; inhalant
12.7
16.9
30
27
R03BA05
ATC
fluticasone; inhalant
4.2
16.8
75
241
J47
ICD-10 Finland
Bronchiectasis
25.5
16.8
23
10
J01MA12
ATC
levofloxacin; systemic
4.3
16.4
69
209
R06.0
ICD-10 Finland
Dyspnoea
3.9
16.1
78
269
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.0
16.0
74
244
GDG10
NOMESCO Finland
Bilateral transplantation of lung
+∞
15.8
15
*
E88.9
ICD-10 Finland
Metabolic disorder, unspecified
+∞
15.8
15
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
6.3
15.8
44
84
R03DC03
ATC
montelukast; oral
4.2
15.8
69
216
R03BA02
ATC
budesonide; inhalant
4.2
15.7
68
211
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.7
15.5
41
73
L04AA06
ATC
mycophenolic acid; systemic
16.7
15.3
24
16
R03AK08
ATC
formoterol and beclometasone; inhalant
10.0
15.0
30
34
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
10.0
15.0
30
34
R03BA01
ATC
beclometasone; inhalant
4.5
14.8
58
163
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
12.6
14.7
26
23
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
160.1
14.6
15
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.0
14.6
67
217
J45.0
ICD-10 Finland
Predominantly allergic asthma
5.6
14.2
43
91
R03BA08
ATC
ciclesonide; inhalant
5.5
14.1
44
96
J45.8
ICD-10 Finland
Mixed asthma
13.3
14.0
24
20
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
16.1
13.9
22
15
J43.1
ICD-10 Finland
Panlobular emphysema
+∞
13.7
13
*
J43.8
ICD-10 Finland
Other emphysema
+∞
13.7
13
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
22.9
13.6
19
9
L04AD01
ATC
ciclosporin; systemic
16.4
13.4
21
14
R03AC03
ATC
terbutaline; inhalant
4.2
12.8
52
150
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
9.3
12.7
26
31
E88.8
ICD-10 Finland
Other specified metabolic disorders
+∞
12.6
12
*
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
13.7
11.4
19
15
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
7.6
11.3
26
38
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
14.9
11.2
18
13
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
3.6
11.1
54
180
J46
ICD-10 Finland
Status asthmaticus
15.2
10.7
17
12
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.6
10.6
134
822
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
10.3
83
390
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.3
10.1
31
66
TGC00
NOMESCO Finland
Bronchial lavation
11.4
10.0
18
17
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.9
9.8
27
51
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.0
9.6
31
70
G47.3
ICD-10 Finland
Sleep apnoea
2.9
9.4
65
276
J01AA02
ATC
doxycycline; systemic
2.8
9.3
181
1360
R03AC13
ATC
formoterol; inhalant
6.6
9.2
23
38
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.3
9.0
49
176
H02AB04
ATC
methylprednisolone; systemic
3.3
8.9
48
171
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.5
8.6
41
134
R01AD09
ATC
mometasone; nasal
2.3
8.4
111
664
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
+∞
8.4
8
*
J96.1
ICD-10 Finland
Chronic respiratory failure
8.7
8.3
17
21
Z01.8
ICD-10 Finland
Other specified special examinations
2.7
8.2
61
270
R05CB01
ATC
acetylcysteine; inhalant, oral
23.0
8.1
11
5
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.7
8.0
35
106
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
13.7
8.0
13
10
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
10.0
7.9
15
16
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
5.3
7.9
23
47
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.5
7.8
27
66
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
15.8
7.8
12
8
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
6.9
7.6
18
28
R03BB01
ATC
ipratropium bromide; inhalant
6.9
7.6
18
28
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
6.4
7.6
19
32
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
14.0
7.5
12
9
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.0
7.5
23
50
H02AB07
ATC
prednisone; oral
3.1
7.4
42
155
J43.2
ICD-10 Finland
Centrilobular emphysema
+∞
7.3
7
*
XX4BW
NOMESCO Finland
NA
+∞
7.3
7
*
C03CA01
ATC
furosemide; systemic
2.6
7.2
56
252
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.8
7.2
50
210
Z50.1
ICD-10 Finland
Other physical therapy
5.0
7.1
22
48
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
3.9
7.0
28
79
R02
ICPC
Shortness of breath/dyspnoea
3.2
6.9
36
126
XG474
NOMESCO Finland
Exhalation nntrogen oxide
6.3
6.8
17
29
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.1
6.6
99
611
R5140
NOMESCO Finland
Monitoring the use of the aid
3.1
6.5
36
129
C10AA03
ATC
pravastatin; oral
5.2
6.5
19
39
R96
ICPC
Asthma
3.6
6.5
28
85
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
7.4
6.3
14
20
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
18.7
6.3
9
5
A02BC02
ATC
pantoprazole; systemic
2.1
6.3
144
1048
A02BC01
ATC
omeprazole; systemic
2.3
6.3
65
335
2776A
ICD-9 Finland
Other and unspecified disorders of metabolism, Other deficiencies of circulating enzymes[DEFECTUS ALFA1-ANTITRYPSINI]
+∞
6.3
6
*
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
27.5
6.3
8
*
J01FA10
ATC
azithromycin; systemic
2.0
6.2
134
950
Z31.5
ICD-10 Finland
Genetic counselling
4.8
6.1
19
42
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023419) Bacteria identified in Sputum by Culture
30
20
16.94
34.53
3.7
2.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
152
625
4.75
32.20
11.6
6.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
42
58
8.53
29.82
6.0
3.1
—
—
—
0
0
(3009343) pH of Capillary blood
59
122
6.05
28.65
4.0
2.9
ph
7.4
7.4
—
9
8
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
56
118
5.85
26.55
4.1
2.9
mmol/l
2.6
1.8
0.89
44
91
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
34
42
9.23
26.29
4.3
1.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
176
895
4.40
25.92
13.0
6.1
%
0.8
0.7
1.62
171
839
(3032080) INR in Blood by Coagulation assay
151
693
4.05
25.75
8.2
6.0
inr
1.1
1.2
0.34
47
197
(3034770) Mitochondria Ab [Titer] in Serum
36
52
7.94
24.46
1.5
1.3
—
—
—
0
0
(4010399)
59
141
5.19
24.18
2.6
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
33
44
8.51
23.95
31.1
6.1
iu/ml
223.0
125.5
—
11
6
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
28
7
44.80
23.21
3.9
1.7
ug/l
37.6
72.3
—
28
7
(3013115) Eosinophils [#/volume] in Blood
186
1029
4.31
23.21
13.0
6.1
e9/l
0.2
0.2
0.23
177
928
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
25
26
10.59
21.81
5.3
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
179
997
3.92
21.34
12.3
5.9
e9/l
0.0
0.0
2.63
169
874
(3019198) Lymphocytes [#/volume] in Blood
182
1026
3.97
21.28
12.1
5.9
e9/l
1.8
2.0
0.47
171
919
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
23
23
10.93
20.58
5.3
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
17
10
18.19
20.47
4.9
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
177
995
3.78
20.43
12.4
5.9
e9/l
0.6
0.6
2.67
168
869
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
71
222
4.09
20.43
2.0
2.1
%
23.4
24.7
0.26
62
201
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
160
856
3.49
19.73
12.7
5.6
mmol/l
1.2
1.2
0.94
141
737
(3024561) Albumin [Mass/volume] in Serum or Plasma
148
758
3.39
19.57
9.4
4.1
g/l
36.7
36.1
0.66
141
715
(44790047)
24
28
9.39
19.22
5.1
1.6
—
—
—
0
0
(44806118)
24
28
9.39
19.22
5.1
1.6
—
—
—
0
0
(44790048)
24
28
9.39
19.22
5.1
1.6
—
—
—
0
0
(44790049)
24
28
9.39
19.22
5.1
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
22
23
10.41
19.06
2.4
2.4
—
—
—
0
0
(3000492) Spirometry study
64
195
4.08
18.97
3.8
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
106
455
3.34
18.61
4.0
3.0
ng/l
857.9
991.7
0.20
96
389
(3022313) Gas panel - Capillary blood
43
98
5.11
18.37
4.5
2.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
75
261
3.70
18.30
3.7
2.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
16
11
15.49
17.78
1.8
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
44
7.05
17.51
4.8
1.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
32
8.20
17.28
4.6
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
31
56
6.19
16.96
4.7
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
24
33
7.95
16.84
4.6
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
21
25
9.09
16.50
2.7
1.9
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
58
5.97
16.36
4.7
1.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
69
245
3.52
16.14
3.1
1.9
s
29.7
29.1
0.25
69
238
(3003458) Phosphate [Moles/volume] in Serum or Plasma
60
195
3.75
16.03
8.3
5.2
mmol/l
1.0
1.1
0.48
54
179
(3037522) Nuclear Ab [Titer] in Serum
74
280
3.35
15.60
1.6
1.4
titre
366.7
529.9
0.66
24
69
(3013650) Neutrophils [#/volume] in Blood by Automated count
184
1164
3.30
15.45
14.8
9.7
e9/l
3.9
3.8
0.18
173
1030
(3024980) IgG subclass 4 [Mass/volume] in Serum
23
34
7.36
15.13
1.8
1.5
g/l
0.6
0.7
0.10
16
28
(3006184) Hemoglobin [Mass/volume] in Capillary blood
22
31
7.70
15.08
1.9
1.7
g/l
134.3
131.3
0.16
15
23
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
38
6.89
14.85
4.7
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
58
194
3.60
14.76
3.9
1.8
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
58
196
3.56
14.52
3.9
1.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
20
27
7.97
14.19
3.6
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
92
417
2.93
14.00
2.5
1.3
g/l
2.6
2.4
0.48
83
261
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
139
792
2.74
13.47
12.3
4.8
mmol/l
1.2
1.2
0.59
127
724
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
19
26
7.84
13.31
1.1
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
65
249
3.19
13.22
1.4
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
69
276
3.08
13.02
5.0
2.8
e6/l
1.0
1.4
0.24
50
159
(3013707) Erythrocyte sedimentation rate by Westergren method
206
1460
3.53
12.96
9.4
3.8
mm/h
12.4
10.6
0.73
198
1356
(3003396) Base excess in Arterial blood by calculation
54
188
3.40
12.81
14.1
5.6
mmol/l
1.7
1.1
0.59
44
146
(3013826) Glucose [Moles/volume] in Serum or Plasma
168
1078
2.76
12.46
12.0
3.8
mmol/l
6.4
6.5
0.31
156
1004
(3001964) Herpes simplex virus Ag [Presence] in Specimen
17
8
22.69
12.18
4.4
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
38
108
3.98
12.13
3.2
3.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
44
141
3.58
11.81
6.1
5.6
%
0.0
0.0
0.49
12
36
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
18
27
7.11
11.63
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
18
27
7.11
11.63
1.2
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
125
717
2.51
11.36
4.1
2.1
nmol/l
78.7
74.4
1.00
116
640
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
85
406
2.67
11.34
2.5
1.7
mg/l
1.5
1.1
0.50
69
306
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
17
26
6.95
10.78
1.2
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
58
232
2.96
10.77
4.0
2.8
umol/l
7.0
8.8
0.56
53
199
(4306422)
16
23
7.37
10.70
1.6
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
15
20
7.92
10.68
1.3
1.3
g/l
0.3
0.3
—
10
14
(4062490)
15
20
7.92
10.68
1.3
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
15
20
7.92
10.68
1.3
1.3
g/l
6.5
6.4
—
10
14
(3028192) IgG subclass 2 [Mass/volume] in Serum
15
20
7.92
10.68
1.3
1.3
g/l
2.3
2.9
—
10
14
(3002179) Metamyelocytes/100 leukocytes in Blood
43
145
3.38
10.63
4.6
5.3
%
0.4
0.3
—
8
35
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
23
49
5.07
10.47
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
27
6.69
10.41
2.5
2.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
16
24
7.06
10.31
1.7
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
57
232
2.90
10.22
4.3
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
65
284
2.75
10.21
3.9
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
105
580
2.41
10.08
3.2
2.2
u/l
64.2
58.7
0.44
99
536
(3021440) Promyelocytes/100 leukocytes in Blood
43
150
3.26
10.05
6.3
5.5
%
0.0
0.1
1.49
14
43
(3026493) Urate [Moles/volume] in Serum or Plasma
94
495
2.45
10.02
8.7
2.5
umol/l
366.7
5729.7
2.04
82
435
(3017181) Myelocytes/100 leukocytes in Blood
45
162
3.18
9.98
6.1
5.2
%
0.3
0.8
1.35
14
52
(3024932) HLA-DR beta [Type]
13
5
27.30
9.91
1.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
13
5
27.30
9.91
1.0
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
57
236
2.84
9.88
1.5
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
141
891
2.36
9.88
17.4
8.6
e9/l
0.0
0.0
0.51
129
721
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
112
642
2.37
9.83
7.2
2.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
101
554
2.40
9.79
7.7
2.8
e6/l
40.0
149.5
0.46
81
428
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
48
4.94
9.74
1.1
1.2
u/ml
405.1
253.9
0.67
16
34
(3030467) Casts [#/volume] in Urine by Automated count
94
501
2.42
9.70
7.6
2.8
e6/l
0.1
0.4
2.41
78
376
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
67
305
2.64
9.66
4.8
2.6
e6/l
0.6
0.8
0.63
49
187
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
191
1394
2.66
9.53
5.5
2.8
u/l
61.0
44.0
2.32
186
1318
(3013290) Carbon dioxide [Partial pressure] in Blood
17
30
6.01
9.41
3.8
2.1
kpa
4.9
5.0
0.05
17
30
(3027315) Oxygen [Partial pressure] in Blood
17
30
6.01
9.41
3.8
2.1
kpa
8.5
8.9
0.22
17
30
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
42
5.09
9.24
1.2
1.4
ug/g
293.5
283.7
—
10
25
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
22
51
4.64
9.07
1.5
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
91
491
2.35
9.02
7.3
2.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
52
4.55
8.86
1.6
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
40
5.06
8.74
4.2
2.9
u/ml
0.3
0.3
—
7
28
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
29
5.83
8.61
3.1
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
182
1329
2.42
8.55
7.6
3.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
31
97
3.51
8.55
20.4
5.6
mmol/l
24.0
25.1
1.11
31
97
(3018095) Leukocytes [#/volume] in Urine
109
650
2.22
8.39
8.6
3.2
e6/l
52.2
83.5
0.36
83
458
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
20
46
4.64
8.31
1.5
1.3
u/ml
110.8
97.3
—
5
7
(3018418) pH of Serum or Plasma
90
503
2.24
8.06
7.5
3.5
ph
7.4
7.4
0.00
25
88
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
17
35
5.14
8.01
2.4
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
56
255
2.55
7.94
1.9
1.9
%
1.5
1.4
0.71
48
228
(3023368) Bacteria identified in Blood by Culture
84
460
2.25
7.87
4.9
4.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
84
461
2.25
7.82
7.7
5.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
29
5.44
7.55
1.2
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
26
79
3.56
7.48
24.1
7.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
65
327
2.34
7.38
1.6
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
70
3.69
7.32
1.1
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
34
4.96
7.27
3.0
4.8
%
51.3
55.9
0.49
16
34
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
5
20.75
7.19
4.8
2.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
123
806
2.05
7.08
3.0
2.4
ug/l
156.6
124.7
0.77
117
745
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
14
27
5.44
7.06
3.4
2.2
—
—
—
0
0
(3019225) pH of Specimen
41
170
2.69
6.98
4.7
3.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
108
681
2.04
6.85
4.7
3.0
ng/l
43.8
40.5
0.09
88
422
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
75
412
2.18
6.85
2.7
1.9
mg/l
3.5
3.2
0.37
64
358
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
32
4.93
6.78
2.9
4.3
e9/l
3.4
4.6
1.31
15
32
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
45
4.24
6.75
1.7
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
14
7.40
6.75
1.7
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
49
228
2.43
6.57
3.2
2.2
ug/g
218.7
107.5
1.24
36
182
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
29
5.06
6.53
1.4
1.3
u/ml
2.6
4.2
—
5
17
(3009871) Measles virus Ab [Titer] in Serum
9
5
18.60
6.31
1.1
1.6
—
—
—
0
0
(3013512) EKG study
88
531
2.02
6.18
5.9
3.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
31
118
2.86
6.17
1.9
3.4
e9/l
71.3
72.5
0.07
25
97
(3021601) Nitrite [Presence] in Urine by Test strip
133
926
1.95
6.16
7.4
4.2
estimate
0.0
0.0
0.00
33
186
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
10
9
11.52
5.85
2.7
1.0
%
101.3
103.8
—
10
9
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
26
93
3.01
5.77
1.7
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
132
930
1.90
5.77
5.1
3.2
estimate
0.0
0.0
0.00
34
184
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
17
6.09
5.67
1.1
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
133
943
1.89
5.67
5.1
3.2
estimate
0.0
0.0
0.50
35
181
(3045788) Cell count panel - Pleural fluid
9
7
13.28
5.62
2.0
2.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
43
3.91
5.46
1.8
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
5
16.46
5.44
3.1
3.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
5
16.46
5.44
1.0
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
36
159
2.48
5.37
1.5
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
18
5.75
5.36
2.1
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
81
496
1.94
5.33
3.6
3.6
mg/mmol
2.9
5.4
1.10
59
304
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
22
5.19
5.31
1.9
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
44
214
2.29
5.30
1.5
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
77
468
1.94
5.16
3.2
3.0
mg/l
640.7
316.9
0.21
56
294
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
8
6
13.72
5.11
1.1
1.0
%
168.6
139.8
—
8
6
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
52
3.44
4.84
1.4
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
53
291
2.05
4.69
6.1
3.4
ng/l
1061.1
431.0
0.90
46
209
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
5
14.35
4.60
1.1
1.0
%
95.7
143.4
—
7
5
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
21
4.92
4.57
2.3
3.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
26
107
2.60
4.47
1.4
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
180
1464
1.86
4.41
4.6
3.7
pmol/l
14.6
14.7
0.38
161
1329
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
12
7.73
4.39
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
12
7.73
4.39
1.1
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
12
7.73
4.39
1.1
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
12
31
4.02
4.31
1.3
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
78
501
1.82
4.30
12.9
7.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
60
355
1.91
4.27
1.3
1.3
iu/ml
15.2
31.8
1.43
17
112
(4035726)
31
144
2.32
4.14
1.7
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
23
4.49
4.13
1.5
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
79
517
1.78
4.06
3.1
2.8
mmol/l
7.4
8.2
0.89
73
435
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
7
7
10.24
4.03
2.9
2.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
76
493
1.78
4.02
3.4
2.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
18
65
2.91
3.95
2.0
3.5
g/l
0.2
0.2
—
10
26
(3000330) Specific gravity of Urine by Test strip
21
84
2.64
3.83
5.1
2.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
16
55
3.04
3.81
2.7
2.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
29
136
2.28
3.79
23.0
6.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
42
229
2.01
3.76
1.7
1.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
84
572
1.71
3.71
6.5
3.2
mmol/l
2.3
2.4
3.09
72
502
(40761536) Microorganisms panel - Urine sediment
32
158
2.18
3.71
5.8
3.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
52
3.01
3.53
2.1
2.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
13
6.32
3.53
2.0
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
13
6.32
3.53
1.1
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
36
190
2.05
3.52
2.8
4.9
ug/l
4.1
64.3
0.81
28
156
(3041096) Erythrocytes [Presence] in Urine by Automated
78
531
1.69
3.41
5.6
2.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
38
3.27
3.26
1.5
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
38
3.27
3.26
1.5
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
226
2054
2.23
3.09
27.5
11.8
mg/l
18.2
23.0
2.25
205
1576
(40760888) Immunoglobulin light chains.free panel - Serum
10
29
3.55
3.08
1.6
4.6
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
6
8
7.65
3.07
1.2
1.4
u/l
8.2
8.8
—
6
8
(3008536) Aspergillus sp Ab [Presence] in Serum
6
8
7.65
3.07
2.0
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
8
7.65
3.07
1.2
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
204
1794
1.80
3.06
5.4
4.3
mu/l
1.8
1.9
0.58
187
1645
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
51
318
1.76
3.02
1.7
1.6
pmol/l
473.6
41818631.7
0.50
44
275
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
13
5.51
2.89
1.6
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
62
415
1.66
2.84
3.6
3.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
117
911
1.54
2.82
5.1
4.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
9
23
4.02
2.80
1.3
1.4
mmol/l
1.5
1.6
—
9
23
(3035880) pH of Pleural fluid
5
6
8.47
2.76
1.2
1.5
—
—
—
0
0
(4015189)
5
6
8.47
2.76
2.0
3.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
14
5.11
2.74
1.6
2.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
41
248
1.78
2.68
3.6
4.0
%
32.3
31.0
0.34
35
172
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
43
2.88
2.68
1.3
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
18
80
2.35
2.68
1.6
2.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
32
3.22
2.67
3.1
1.8
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
20
4.10
2.59
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
20
4.10
2.59
11.5
4.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
20
4.10
2.59
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
20
4.10
2.59
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
7
7.26
2.56
3.8
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
59
400
1.62
2.55
1.6
2.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
27
145
1.97
2.54
25.2
5.1
mmol/l
1.5
1.3
0.71
27
140
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
16
4.47
2.49
1.9
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
21
3.90
2.48
1.1
1.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
31
177
1.86
2.44
3.5
2.6
u/l
29.8
33.9
0.29
25
157
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
233
2176
2.34
2.41
19.2
9.7
u/l
32.8
27.1
4.84
233
2111
(3044640) Blood type and Crossmatch panel - Blood
83
617
1.52
2.40
3.4
2.3
—
—
—
0
0
(44813793)
5
8
6.35
2.38
1.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
157
1332
1.49
2.35
3.3
3.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
66
469
1.56
2.33
3.4
2.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
90
685
1.49
2.31
2.1
1.8
pmol/l
97.1
100.0
0.23
54
348
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
23
3.56
2.29
1.6
2.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
23
3.56
2.29
1.6
2.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
23
3.56
2.29
1.6
2.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
7
18
3.97
2.27
1.0
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
21
108
2.03
2.23
30.4
6.5
%
93.7
94.0
0.12
21
108
(3017704) Immunofixation for Urine
5
9
5.64
2.22
1.0
1.8
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
9
5.64
2.22
2.0
2.0
u/l
13.8
15.2
—
5
9
(40768804) Tissue Pathology biopsy report
100
783
1.47
2.21
2.9
2.0
—
—
—
0
0
(4268621)
8
24
3.41
2.20
2.4
2.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
19
3.76
2.16
1.6
1.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
19
3.76
2.16
1.1
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
19
3.76
2.16
1.6
1.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
19
3.76
2.16
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
19
3.76
2.16
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
19
3.76
2.16
1.6
1.7
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
19
3.76
2.16
1.3
1.1
%
92.6
91.1
—
7
19
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
19
3.76
2.16
1.6
1.7
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
7
19
3.76
2.16
1.0
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
23
124
1.94
2.15
2.7
1.9
e9/l
4.5
3.8
0.57
16
105
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
71
522
1.51
2.14
1.7
1.6
mmol/l
1.4
1.4
0.02
63
442
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
10
37
2.77
2.13
1.7
3.8
—
3.5
—
0
6
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
43
2.63
2.12
1.5
1.9
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
15
69
2.25
2.09
4.5
1.9
%
0.9
1.6
1.94
15
69
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
210
1916
1.66
2.09
22.6
10.8
ml/min/173m2
83.6
84.6
0.27
195
1577
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
20
3.57
2.07
1.6
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
20
3.57
2.07
1.6
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
15
4.07
2.05
1.0
1.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
15
4.07
2.05
3.0
2.4
mmol/l
107.5
105.7
—
6
15
(3041354) Potassium [Moles/volume] in Venous blood
6
15
4.07
2.05
3.0
2.4
mmol/l
4.2
4.1
—
6
15
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
15
4.07
2.05
2.8
1.4
g/l
0.9
1.1
—
6
15
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
15
4.07
2.05
3.0
2.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
62
447
1.52
2.04
1.3
1.2
u/ml
0.6
1.2
0.76
16
132
(3002032) Base excess in Venous blood by calculation
25
142
1.85
2.02
6.7
3.4
mmol/l
1.7
2.5
0.62
19
106
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
21
3.40
1.98
2.3
1.5
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
5
11
4.61
1.95
1.8
1.6
umol/l
10.3
10.7
—
5
11
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
211
1937
1.63
1.93
4.8
3.7
mmol/l
1.3
1.3
0.21
202
1799
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
217
2006
1.69
1.93
5.4
4.1
mmol/l
4.8
4.8
0.07
207
1877
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
23
3.10
1.81
1.0
1.0
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
60
2.23
1.81
1.3
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
47
2.40
1.80
1.3
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
228
2145
1.86
1.78
20.6
10.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
41
2.50
1.78
6.9
3.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
36
2.56
1.76
2.1
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
13
3.90
1.72
1.8
2.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
13
3.90
1.72
2.2
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
13
3.90
1.72
1.8
2.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
13
3.90
1.72
1.8
2.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
13
3.90
1.72
1.8
2.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
24
142
1.76
1.72
7.0
3.4
kpa
5.5
5.8
0.44
24
137
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
15
76
2.04
1.68
7.7
2.6
%
52.6
48.9
0.23
15
76
(3013139) Helicobacter pylori Ag [Presence] in Stool
20
114
1.82
1.62
1.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
37
251
1.56
1.60
1.2
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
20
3.05
1.59
1.8
2.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
53
391
1.45
1.55
1.9
1.5
nmol/l
19.4
20.7
0.31
45
332
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
91
739
1.37
1.54
5.5
3.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
15
3.38
1.53
1.6
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
53
392
1.45
1.53
1.3
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
237
0.52
1.48
2.2
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
15
80
1.93
1.48
1.4
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
214
2000
1.54
1.47
5.4
4.0
mmol/l
1.5
1.5
0.61
203
1865
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
52
2.17
1.46
1.2
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
28
2.54
1.46
1.3
2.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
42
301
1.48
1.42
1.8
1.6
nmol/l
1201.1
1220.2
0.05
34
236
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
175
1.61
1.42
3.1
3.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
42
2.19
1.35
1.4
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
46
340
1.43
1.33
1.4
1.3
u/ml
12.2
8.8
0.13
16
145
(3019832) Treponema pallidum Ab [Presence] in Serum
32
220
1.52
1.32
1.4
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
43
2.13
1.31
1.7
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
34
2.40
1.30
1.3
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
62
1.98
1.30
2.0
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
18
2.81
1.29
6.0
2.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
35
2.33
1.28
1.6
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
25
2.43
1.25
5.7
2.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
203
1895
1.41
1.23
26.3
12.6
%
39.9
40.5
0.40
150
1468
(3049717) Cytology report of Urine Cyto stain
13
71
1.88
1.22
4.0
2.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
26
2.34
1.19
1.0
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
215
2033
1.46
1.15
5.7
4.5
mmol/l
2.8
2.9
0.86
207
1895
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
36
0.00
1.15
0.0
3.4
—
40.6
—
0
36
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
32
228
1.46
1.13
2.0
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
17
104
1.68
1.12
3.2
2.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
31
2.29
1.11
1.1
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
31
2.29
1.11
2.4
1.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
20
129
1.60
1.09
5.8
2.6
kpa
4.4
4.8
0.58
20
124
(3015171) Extractable nuclear Ab [Units/volume] in Serum
15
90
1.71
1.06
1.5
1.3
—
0.3
—
0
6
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
20
130
1.59
1.06
1.5
1.3
—
39.3
—
0
10
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
33
2.15
1.06
1.3
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
12
68
1.80
1.02
3.5
3.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
196
1836
1.33
1.02
6.5
4.9
mmol/mol
39.5
38.7
0.59
182
1720
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
132
1.56
1.00
1.2
1.4
iu/ml
360.6
101.3
—
8
60
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
85
1.69
0.96
2.9
2.1
—
—
—
0
0
(3020891) Body temperature
12
72
1.70
0.87
7.4
3.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
31
1.96
0.85
1.3
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
148
1362
1.22
0.77
6.8
3.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
70
597
1.24
0.77
1.8
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
6
34
1.78
0.77
3.8
2.9
ug/min
4.0
135.3
—
6
18
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
24
2.11
0.75
1.4
2.5
nmol/l
2.4
2.6
—
5
24
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
107
0.55
0.74
1.7
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
38
1.87
0.74
1.3
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
61
521
1.23
0.66
5.5
3.5
estimate
0.0
0.0
0.00
35
181
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.3
—
39.0
—
0
5
(3035941) MCH [Entitic mass]
235
2300
1.49
0.57
35.7
17.6
pg
30.4
30.3
0.41
235
2266
(3024731) MCV [Entitic volume]
235
2300
1.49
0.57
35.7
17.6
fl
91.3
90.7
1.33
235
2267
(3026361) Erythrocytes [#/volume] in Blood
235
2301
1.48
0.56
35.8
17.6
e12/l
4.6
4.6
0.11
235
2240
(3010813) Leukocytes [#/volume] in Blood
235
2302
1.47
0.54
35.9
17.7
e9/l
6.8
6.5
1.51
235
2240
(3000963) Hemoglobin [Mass/volume] in Blood
235
2303
1.46
0.53
36.2
17.7
g/l
136.5
137.5
0.44
235
2270
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
168
0.70
0.52
1.5
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
14
103
1.38
0.46
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
229
0.77
0.45
1.7
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
51
579
0.85
0.44
3.3
4.2
%
22.4
21.3
0.21
20
266
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
199
1923
1.18
0.44
5.0
4.1
mmol/l
5.8
5.8
0.46
182
1774
(3022621) pH of Urine by Test strip
17
131
1.32
0.43
2.2
2.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
234
2299
1.37
0.42
36.0
17.7
e9/l
247.5
248.4
0.07
234
2245
(3002523) Influenza virus A Ag [Presence] in Specimen
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
105
1.35
0.42
1.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
103.7
—
0
15
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
258.4
—
0
9
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
33.8
—
0
9
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
15
0.00
0.41
0.0
1.6
—
19.0
—
0
10
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
526.3
—
0
9
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
59
1.37
0.41
1.3
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
35
1.44
0.39
1.6
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
77
703
1.14
0.39
4.0
4.6
ug/l
1.8
2.6
0.61
69
642
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
18
144
1.27
0.36
2.7
2.6
ml/min/173m2
42.8
72.0
—
8
61
(40761535) Cells panel - Urine sediment
18
145
1.26
0.35
1.9
3.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
109
1.30
0.34
1.8
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
47
1.28
0.32
1.5
1.9
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
64
1.26
0.27
5.1
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
127
0.78
0.26
1.5
2.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
83
779
1.10
0.26
3.3
2.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
82
0.73
0.24
2.0
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
18
152
1.20
0.24
1.6
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
38
1.32
0.23
1.2
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
38
1.32
0.23
1.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
104
0.76
0.21
2.3
1.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
10
0.00
0.21
0.0
1.3
—
8.0
—
0
10
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
10
0.00
0.21
0.0
1.4
—
1.0
—
0
5
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
15.3
—
916.9
—
0
13
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
7.7
—
0.6
—
0
13
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
24.8
—
1401.3
—
0
13
(3006462) Nitrate [Presence] in Urine
0
13
0.00
0.21
0.0
4.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
13
0.00
0.21
0.0
1.7
—
4.0
—
0
5
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(4211845)
0
14
0.00
0.20
0.0
3.8
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
14
0.00
0.20
0.0
1.1
—
283.7
—
0
14
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
19
214
0.88
0.16
1.2
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
23
255
0.89
0.16
1.6
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
80
1.13
0.15
1.4
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
182
1788
1.07
0.14
29.1
15.3
g/l
333.1
333.2
0.04
182
1780
(21494755) Public health laboratory ask at order entry panel
22
242
0.90
0.13
1.3
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
45
1.11
0.10
6.8
1.5
g/l
0.0
0.0
—
5
45
(3019150) Specific gravity of Urine by Refractometry
43
410
1.06
0.09
4.3
3.4
kg/l
1.0
1.0
0.05
14
63
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
60
0.83
0.08
1.2
1.5
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
5
62
0.80
0.08
2.2
1.3
iu/l
30.3
24.6
—
5
53
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
67
1.05
0.08
1.3
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
92
0.87
0.07
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
9
101
0.89
0.06
1.4
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
289
0.96
0.02
1.6
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
24
234
1.03
0.00
6.0
6.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
43
436
0.98
0.00
1.9
3.0
ug/l
0.8
0.7
0.14
21
275
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
11
105
1.05
0.00
1.4
1.7
—
—
—
0
0
(1002224) Polysomnography panel
10
95
1.05
0.00
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
70
1.00
0.00
1.4
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(4198724)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
58
0.86
0.00
1.0
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
50
1.00
0.00
1.6
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
5
53
0.94
0.00
6.8
1.5
g/l
38.9
37.6
—
5
48
(3024263) Appearance of Synovial fluid
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
58
0.86
0.00
1.0
1.5
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
6.2
—
0
5
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
1.0
—
0
5
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
58
0.86
0.00
1.0
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
58
0.86
0.00
1.0
1.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
100.5
—
0
6
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
51
0.98
0.00
1.2
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_PLASMAPROT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_PLASMAPROT | 2.638 [1.89, 3.68] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.116 |
During the follow-up period (1.1.1998 — 31.12.2019), 87 out of 555 females with E4_PLASMAPROT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_PLASMAPROT | 3.193 [2.5, 4.09] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 153 out of 681 males with E4_PLASMAPROT died.
Mortality risk
Mortality risk for people of age
years, who have E4_PLASMAPROT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.2% | 0.625% |
| 5 | 1.247% | 3.59% |
| 10 | 3.249% | 8.999% |
| 15 | 6.513% | 16.458% |
| 20 | 11.882% | 26.107% |
Relationships between endpoints
↥Index endpoint: E4_PLASMAPROT – Disorders of plasma-protein metabolism, not elsewhere classified
GWS hits: 8
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data